文献速递乳腺癌

黏液性乳腺癌的临床特征及复发危险因素

[Clinical features and risk factors for recurrence in mucinous breast cancer].
PubMed 文献 · Zhonghua Zhong Liu Za Zhi · 2017-01-01

回顾性分析浙江省肿瘤医院2005年8月至2012年11月97例黏液性乳腺癌患者,按黏液成分比例分为部分混合型43例、主要混合型16例和纯型38例,中位随访65个月,3年和5年无复发生存率分别为90.7%和85.7%,肿瘤大小、PR状态和术后放疗是复发的独立预后因素。

要点

  • 不同黏液性乳腺癌亚型在肿瘤大小、淋巴结转移数目、腋窝淋巴结转移、TNM分期和p53突变状态上存在差异(均P<0.05)。
  • 绝经状态和TNM分期与复发相关(均P<0.05),绝经和Ⅲ-Ⅳ期患者无复发生存时间显著缩短。
  • 肿瘤大小(>30 mm)、PR状态和术后放疗是黏液性乳腺癌复发的独立预后因素,黏液成分比例与复发无关。

核心结论

  • 肿瘤大小、腋窝淋巴结转移状态、TNM分期和p53突变状态在不同黏液性乳腺癌亚型间存在差异。
  • 肿瘤大小(>30 mm)、PR状态和术后放疗是复发的独立预后因素,而黏液成分比例与黏液性乳腺癌患者复发无关。

研究设计与样本

  • 回顾性分析浙江省肿瘤医院2005年8月至2012年11月97例黏液性乳腺癌患者的临床资料。
  • 按肿瘤中黏液成分比例分为部分混合型(黏液成分<50%)43例、主要混合型(黏液成分50%~90%)16例和纯型(黏液成分>90%)38例。
  • 通过门诊、住院系统和电话收集随访资料,采用χ²检验、Kaplan-Meier曲线联合Log-rank检验及Cox比例风险回归模型进行统计分析。

主要发现

  • 中位随访时间65个月(范围24~125个月),97例患者中14例在终点时出现复发或转移。
  • 3年和5年无复发生存率分别为90.7%和85.7%。
  • 肿瘤大小、淋巴结转移数目、腋窝淋巴结转移、TNM分期和p53突变状态均与黏液性乳腺癌亚型相关(均P<0.05)。
  • 黏液性乳腺癌亚型与手术年龄、ER状态、PR状态、HER-2过表达、月经状态和疾病复发均无相关性(均P>0.05)。
  • 单因素分析显示月经状态和TNM分期与乳腺癌复发相关(P<0.05),绝经和Ⅲ-Ⅳ期患者无复发生存时间显著缩短(均P<0.05)。

关键数值与推荐

  • 部分混合型、主要混合型和纯型黏液性乳腺癌分别纳入43例、16例和38例。
  • 3年和5年无复发生存率分别为90.7%和85.7%。
  • 肿瘤大小、淋巴结转移数目、腋窝淋巴结转移、TNM分期和p53突变状态与亚型相关(均P<0.05)。
  • 月经状态和TNM分期与复发相关(P<0.05),绝经和Ⅲ-Ⅳ期患者无复发生存时间显著缩短(均P<0.05)。
  • 肿瘤大小、PR状态和术后放疗是复发的独立预后因素。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate the clinicopathological characteristic and risk factors for recurrence in different subtypes of mucinous breast cancer(MBC). Methods: Clinical data of 97 MBC patients at Zhejiang Cancer Hospital from August 2005 to November 2012 were retrospectively analyzed. All of patients were divided into 3 subtypes according to the mucinous components in the tumors, named as partial mixed MBC with less than 50% of mucinous components, main mixed MBC where the mucinous component accounted for 50% to 90%, and pure MBC with more than 90% of mucinous components. In this study, 43, 16 and 38 patients were included in partial mixed MBC, main mixed MBC, and pure MBC, respectively. Follow-up was collected by out-patient, in-patient system and phone call. The relationship between different subtypes and clinicopathological significance were analyzed by χ(2) test. Kaplan-Meier curve combined with Log-rank test was used to evaluate the risk factors of relapse free survival(RFS) at 3- and 5-year. Cox proportional hazard regression model was used for multivariate analysis. Results: The median follow-up time was 65 months (range 24-125). Of the 97 patients, 14 patients were relapse or metastasis at the end point. The 3- and 5-year RFS were 90.7% and 85.7%, respectively. Tumor size, number of involved lymph nodes (LN), axillary LN metastasis, TNM stages and p53 mutant status were all related with subtypes of MBC(all of P<0.05). There was no correlation between subtypes of MBC and the other parameters, including age at surgery, estrogen receptor (ER) status, progesterone receptor (PR) status, human epidermal growth factor receptor-2 (HER-2) overexpression, menstruation status, and the relapse of disease(all of P>0.05). Univariate analysis showed menstruation status and TNM stages were associated with the relapse of breast cancer(P<0.05). The patients with menopause and stage Ⅲ-Ⅳ showed significantly shorter RFS time(both of P<0.05). Multivariate Cox proportional hazard regression analysis revealed that tumor size, PR status and postoperative radiotherapy were the independent prognostic factors for the relapse of MBC. Conclusions: Tumor size, status of axillary LN metastasis, TNM stages, and p53 mutation status are differ among different subtypes of MBC. The tumor size (>30 mm), PR status and postoperative radiotherapy are the independent risk factors for recurrence, whereas the proportion of the mucinous component is not associated with relapse in MBC patients.

来源:Zhonghua Zhong Liu Za Zhi,查看原文。版权归原作者所有。

引用

  1. Lei L, Chen ZZ, Zheng YB, et al. [Clinical features and risk factors for recurrence in mucinous breast cancer]. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 28550667. doi:10.3760/cma.j.issn.0253-3766.2017.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。